Psychedelic Lobbying and Regulatory Capture
Not all lobbying campaigns are problematic — the goal should be for regulators to leverage industry insights while maintaining independence in decision-making.

Not all lobbying campaigns are problematic — the goal should be for regulators to leverage industry insights while maintaining independence in decision-making.

Organoids purport to tell us a great deal about the human body. Here are some legal questions to consider as the technology is widely adopted in R&D — and beyond.

For millions who work in health care settings, including doctors, nurses, technicians, home health and nursing home workers, and environmental services and nutrition specialists, the difficult days of the COVID-19 pandemic greatly amplified existing concerns about work conditions, staffing shortages, patient safety, and risks to their own health and wellbeing. Stressful conditions have contributed to…

WHOOP announced their product is eligible for FSA and HSA spending. That might change the way we think about the tax code and health policy.

We marked the publication of COVID-19 and the Law: Disruption, Impact and Legacy, an edited volume based on the Petrie-Flom Center’s 2021 annual conference, published in partnership with the Solomon Center for Health Law and Policy at Yale Law School. In this moderated discussion, prominent experts and contributors to the volume will reflect on the ethical, legal,…

There is little consensus in defining “psychedelic.” Yet, research on and access to these substances hinges on what gets included under this umbrella.

This #MaternalHealthAwarenessDay, insist on comprehensive Medicaid coverage for moms.

This concluding post attempts to synthesize contributions to the symposium “From Principles to Practice: Human Rights and Public Health Emergencies”
